Evidence mapPaperPMID 34439753Full record

ArticleBiomolecules2021

Altered L-Arginine Metabolic Pathways in Gastric Cancer: Potential Therapeutic Targets and Biomarkers.

Iwona Bednarz-Misa, Mariusz G Fleszar, Paulina Fortuna, Łukasz Lewandowski, Magdalena Mierzchała-Pasierb, Dorota Diakowska, Małgorzata Krzystek-Korpacka

Open access · goldAbstract read
In one paragraph

Article in Biomolecules, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 47 citations in OpenAlex.

  1. Article
  2. Correlation analysis of gut microbiota and metabolites in gastric cancer patients in plateau areas based on multi-omics technologies.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026
    Article
  3. Article
  4. Review
  5. Review
  6. Metabolic reprogramming as a key regulator in Helicobacter pylori-infected gastric cancer.Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association · 2026
    Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Molecular Mechanisms ofPharmaceuticals (Basel, Switzerland) · 2025
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Iwona Bednarz-MisaDepartment of Biochemistry and Immunochemistry, Wroclaw Medical University, 50-368 Wroclaw, Poland.ORCID 0000-0001-7244-2017
Mariusz G FleszarDepartment of Biochemistry and Immunochemistry, Wroclaw Medical University, 50-368 Wroclaw, Poland.ORCID 0000-0001-7857-327X
Paulina FortunaDepartment of Biochemistry and Immunochemistry, Wroclaw Medical University, 50-368 Wroclaw, Poland.ORCID 0000-0003-4617-798X
Łukasz LewandowskiDepartment of Biochemistry and Immunochemistry, Wroclaw Medical University, 50-368 Wroclaw, Poland.ORCID 0000-0002-7624-631X
Magdalena Mierzchała-PasierbDepartment of Biochemistry and Immunochemistry, Wroclaw Medical University, 50-368 Wroclaw, Poland.ORCID 0000-0001-9640-4883
Dorota DiakowskaDepartment of Gastrointestinal and General Surgery, Wroclaw Medical University, 50-368 Wroclaw, Poland.ORCID 0000-0002-1377-5601
Małgorzata Krzystek-KorpackaDepartment of Biochemistry and Immunochemistry, Wroclaw Medical University, 50-368 Wroclaw, Poland.ORCID 0000-0002-2753-8092
Wroclaw Medical University · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

There is a pressing need for molecular targets and biomarkers in gastric cancer (GC). We aimed at identifying aberrations in L-arginine metabolism with therapeutic and diagnostic potential. Systemic metabolites were quantified using mass spectrometry in 293 individuals and enzymes' gene expression was quantified in 29 paired tumor-normal samples using qPCR and referred to cancer pathology and molecular landscape. Patients with cancer or benign disorders had reduced systemic arginine, citrulline, and ornithine and elevated symmetric dimethylarginine and dimethylamine. Citrulline and ornithine depletion was accentuated in metastasizing cancers. Metabolite diagnostic panel had 91% accuracy in detecting cancer and 70% accuracy in differentiating cancer from benign disorders. Gastric tumors had upregulated

Indexed as

Gene Expression Regulation, NeoplasticAgedArginineArgininosuccinate LyaseCell DifferentiationCitrullineDNA, ComplementaryFemaleGene Expression ProfilingHumansIntracellular Signaling Peptides and ProteinsMaleMass SpectrometryMetabolomicsMiddle AgedMitochondrial Membrane Transport ProteinsArginineArgininosuccinate LyaseCitrullineDNA, ComplementaryIntracellular Signaling Peptides and ProteinsMitochondrial Membrane Transport ProteinsNitric Oxide Synthase Type IINOS2 protein, humanOrnithinePRMT2 protein, humanProtein-Arginine N-MethyltransferasesSLC25A15 protein, humanarginine auxotrophyargininosuccinate lyaseargininosuccinate synthasedimethylargininedimethylarginine dimethylaminohydrolasemetabolic reprogrammingnitric oxide synthaseornithine decarboxylaseornithine translocaseprotein arginine methyltransferase

Identifiers

PMID34439753
PMCPMC8395015
OpenAlexW3186109774

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.